Dr RishiRaj Sinha/LinkedIn
Nov 9, 2025, 11:29
Dr RishiRaj Sinha Highlights Ways to Participate in ISSCR 2026 Meeting
Dr RishiRaj Sinha, Member, Public Health Partnerships Subgroup Working Party at International Society of Blood Transfusion (ISBT), posted on LinkedIn:
“There are many ways to make your voice heard and participate in all that the ISSCR2026 Annual Meeting has to offer! Discover how to get involved, including submitting an abstract, proposing a science spotlight, hosting a meet-up hub, and more here!
Discover how to get involved:
- Submit an abstract and share your latest research on a global stage
- Propose a Science Spotlight or Innovation Showcase
- Host or attend a Meet-Up Hub to connect with peers and thought leaders
- Volunteer for session moderation or poster judging
- Participate in mentoring and networking sessions for early-career researchers
The International Society for Stem Cell Research Annual Meeting is the world’s leading forum for advancing the frontiers of stem cell science and regenerative medicine, connecting thousands of researchers, clinicians, policymakers, and industry experts from across the globe.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
